Document Detail


Clinical and experimental studies of intraoperative autotransfusion using a new filtration device.
MedLine Citation:
PMID:  7627507     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The Haemocell S-350 device has recently been introduced for intraoperative autotransfusion. The system uses a novel membrane filter to process shed blood. In the first part of this study a 0.2-micron pore size filter was used in a randomized trial comparing the use of autotransfusion (n = 8) with bank blood controls (n = 9) during aortic reconstruction. This part of the trial was abandoned because of unexpected non-surgical bleeding. Bank blood requirements fell from a median of 3.0 (range 0.0-9.0) units to 1.5 (range 0.0-7.0) units when autotransfusion was used, but these patients had a greater perioperative blood loss (1791 (range 932-3104) versus 1140 (range 440-3840) ml). There was evidence of postoperative heparin excess with an activated partial thromboplastin time ratio of 1.3 (range 0.9-3.0) versus 1.0 (range 1.0-1.2) in controls and an activated clotting time of 206 (range 143-280) versus 137 (range 107-142) s. This was confirmed by raised plasma heparin levels and a prolonged thrombin time normalized by protamine. To improve performance a 0.6-micron pore size filter was studied in ten patients. Filtration efficiency doubled from 19 to 38 per cent. Electron micrographs demonstrated better filter clearance, but 44 per cent of the original concentration of heparin remained in the reinfusate. The S-350 device may be an attractive alternative to centrifugation for intraoperative autotransfusion but, until efficiency is improved, it should only be used for cardiovascular surgery when excess heparin can be reversed with protamine.
Authors:
Z A Varga; J F Thompson; J C Locke-Edmunds; R N Baird; J R Farndon
Related Documents :
18444947 - Complement split products and proinflammatory cytokines in intraoperatively salvaged un...
3805107 - Heparin neutralising activity of whole blood in patients undergoing vascular surgery.
15141797 - Can we rely on arterial line sampling in performing activated plasma thromboplastin tim...
1854557 - The effect of heparin on three whole blood activated clotting tests and thrombin time.
9426637 - The effects of diaspirin-crosslinked hemoglobin on the assessment of immunohematology p...
7912867 - Estimates of pulse wave velocity and measurement of pulse transit time in the human cer...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The British journal of surgery     Volume:  82     ISSN:  0007-1323     ISO Abbreviation:  Br J Surg     Publication Date:  1995 Jun 
Date Detail:
Created Date:  1995-09-05     Completed Date:  1995-09-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372553     Medline TA:  Br J Surg     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  765-9     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, Bristol Royal Infirmary, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aortic Aneurysm, Abdominal / blood,  surgery
Blood Platelets
Blood Transfusion, Autologous / instrumentation*
Filtration / instrumentation*
Hemoglobins / analysis
Humans
Partial Thromboplastin Time
Chemical
Reg. No./Substance:
0/Hemoglobins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lysis-assisted angioplasty in the treatment of lower-limb arterial thrombosis.
Next Document:  Granulocyte-macrophage colony-stimulating factor modulates immune function and improves survival aft...